Drug Shortage Report for SOLU-CORTEF

Last updated on 2024-02-27 History
Report ID 210575
Drug Identification Number 00030627
Brand name SOLU-CORTEF
Common or Proper name SOLU-CORTEF
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) HYDROCORTISONE
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 4mL AOV
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-12-22
Actual start date
Estimated end date
Actual end date 2024-02-26
Shortage status Resolved
Updated date 2024-02-27
Company comments Other presentations remain available.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-02-27 English Compare
v12 2024-02-26 French Compare
v11 2024-02-26 English Compare
v10 2024-01-31 French Compare
v9 2024-01-31 English Compare
v8 2023-12-23 English Compare
v7 2023-12-13 French Compare
v6 2023-12-13 English Compare
v5 2023-12-12 English Compare
v4 2023-11-30 French Compare
v3 2023-11-30 English Compare
v2 2023-11-17 French Compare
v1 2023-11-17 English Compare

Showing 1 to 13 of 13